| Drug Name |
Interferon gamma-1b |
| Drug ID |
BADD_D01171 |
| Description |
Human Interferon gamma-1b (140 residues), produced from E. coli. Production of Actimmune is achieved by fermentation of a genetically engineered Escherichia coli bacterium containing the DNA which encodes for the human protein. Purification of the product is achieved by conventional column chromatography.
The sequence displayed is a cDNA sequence which codes for human interferon gamma, as described by Gray et. al. and not specifically interferon gamma 1b. |
| Indications and Usage |
Interferon gamma-1b is used for the treatment of Chronic granulomatous disease and Osteopetrosis. |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB00033
|
| KEGG ID |
D00747
|
| MeSH ID |
C554125
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0U9EN
|
| NDC Product Code |
17089-378; 75987-111 |
| UNII |
21K6M2I7AG
|
| Synonyms |
interferon gamma-1b | interferon gamma-2a | Actimmune |
